Back

Endotrophin, quantified by a novel assay, is prognostic of all-cause mortality in two different cohorts of patients with heart failure with preserved ejection fraction

18 May 2025 (16:51 - 17:00)
Organised by: Logo
Congress Presentation Part of: Pathophysiology, detection and biomarkers Biomarkers HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Ms Elisavet Angeli

Copenhagen (Denmark)

6 More presentations in this session

Presentation thumbnail
Linking brain innate immunity, energy metabolism, and HFpEF: hypothalamic complement C3/C3a/C3aR pathway drives cardiometabolic syndrome and HFpEF via central SOCS3 activation
Doctor E. Rawish (Luebeck, DE)
Abstract Slides
Presentation thumbnail
Investigating the role of the long non-coding RNA lncFOX in cardiovascular disease
Ms L. Oehlsen (Hannover, DE)
Abstract Slides Video
Presentation thumbnail
Inflammation in acute myocarditis: single-cell RNA sequencing identifies key immune cell signatures and disease progression markers
Doctor C. Panico (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Titin mediates control of cardiomyocyte proliferation
Doctor A. Paldino (Trieste, IT)
Abstract Slides Video
Presentation thumbnail
Development of a remote assessment technique to measure the interstitial fluid pressure for fluid status monitoring in heart failure
Doctor H. Zafar (Sheffield, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiology, detection and biomarkers
Video

The Event

Event poster

Heart Failure 2025

18 May 2025 16:51 CET
You may be interested in
thumbnail
Congress Session
Contemporary biomarkers for diagnosis, monitoring, and prognosis in heart failure
thumbnail
Congress Session
Biomarkers definning pathophysiology and prognosis
thumbnail
Congress Presentation
The landscape of biomarkers in HFpEF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources